Trovagene is exploring the activity of its PLK1 inhibitor onvansertib in three biomarker-defined cancer indications and, based on […]

Factory shutdowns across China because of the new coronavirus have exposed an uncomfortable health-care reality: Many medicines rely on raw materials that are made in that country. The U.S. Food and Drug Administration late Thursday said one drug […]

With a new CEO at the helm, the Laboratory for Advanced Medicine (LAM) is preparing for the launch of its first liquid biopsy — a blood test designed to detect early-stage liver cancer, expected to win approvals starting in China this year […]